Suppr超能文献

2024年5月贝尔格莱德人群对麻疹、腮腺炎和风疹病毒的群体免疫

Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024.

作者信息

Popova Anna Y, Smirnov Vyacheslav S, Egorova Svetlana A, Dragačević Luka, Milichkina Angelica M, Protić Jelena, Danilova Ekaterina M, Drozd Irina V, Petrušić Marija, Zhimbaeva Ojuna B, Glazkova Elizaveta S, Gutić Nataša, Ivanov Valeri A, Ramsay Edward S, Kotsar Oleg V, Smolensky Vyacheslav Y, Totolian Areg A

机构信息

Federal Service for the Oversight of Consumer Protection and Welfare,127994 Moscow, Russia.

Saint Petersburg Pasteur Institute, 197101 St. Petersburg, Russia.

出版信息

Vaccines (Basel). 2025 Jun 18;13(6):652. doi: 10.3390/vaccines13060652.

Abstract

In the Republic of Serbia, measles vaccination was first introduced in 1971, while combined vaccination (measles, mumps, rubella) was made mandatory in 1996 as part of the national vaccination program. Reported prevalence values for 2023 were <0.75 cases per 100K population for measles, 0.09 cases per 100K for mumps, and no cases of rubella. : This cross-sectional study was performed in May, 2024 as part of the project "Herd Immunity to Vaccine-Preventable and Other Relevant Infections in the Belgradian Population." It focused on assessing herd immunity to measles, mumps and rubella (MMR) among residents insofar as these remain a public concern despite the availability of vaccines. A total of 2533 subjects were distributed across nine age groups, covering those aged 1-70 years and various professional groups residing in Belgrade. Participants were stratified by age and activity. Upon obtaining individual information by online questionnaire and receiving a signed statement of informed consent, blood samples were obtained for IgG antibody testing (ELISA) to determine MMR serological status. The results were compared to national and international immunization standards to evaluate herd immunity levels. : Our results indicate varying levels of immunity for each virus, with specific demographic groups showing different immunity levels. Total measles seroprevalence during this study was 74.7%, with significant variation across all age groups. While high seropositivity was observed in both children (90.7%) and elder age groups (98.4%), middle-aged individuals in the age group 30-49 years showed significantly lower IgG levels. Between 2021 and 2023, there were no registered cases of rubella detected in Serbia, which indicates a high level of immunity. This was confirmed here with consistently high IgG levels across all age groups, with an average seropositivity of 94.8%. Average mumps seropositivity across all age groups was 85.1%. The lowest value was in the young child (1-5 years) age group (76.1%); the highest was in the elderly group (92.6%). : The current findings suggest that the Belgradian population has strong overall immunity to MMR, yet with some concerns regarding measles immunity in middle-aged adults, suggesting a potential need for catch-up vaccinations. While rubella status indicates strong herd immunity and minimal risk of outbreaks, mumps immunity in some groups (children, middle-aged adults) is below the protective threshold. While it is still sufficient to prevent widespread transmission, it should be closely observed. To our knowledge, this study is the first of its kind to provide data about MMR seroprevalence in Belgrade. Findings indicate the need for constant surveillance and revaccination of vulnerable/seronegative groups.

摘要

在塞尔维亚共和国,麻疹疫苗接种于1971年首次引入,而联合疫苗接种(麻疹、腮腺炎、风疹)于1996年成为国家疫苗接种计划的一部分并强制实施。2023年报告的患病率为:麻疹每10万人口<0.75例,腮腺炎每10万人口0.09例,风疹无病例。:这项横断面研究于2024年5月进行,是“贝尔格莱德人群对疫苗可预防及其他相关感染的群体免疫”项目的一部分。该研究重点评估居民对麻疹、腮腺炎和风疹(MMR)的群体免疫情况,因为尽管有疫苗可用,但这些疾病仍然是公众关注的问题。共有2533名受试者分布在九个年龄组中,涵盖1至70岁的人群以及居住在贝尔格莱德的不同职业群体。参与者按年龄和活动进行分层。通过在线问卷获取个人信息并收到知情同意书签名声明后,采集血样进行IgG抗体检测(ELISA)以确定MMR血清学状态。将结果与国家和国际免疫标准进行比较,以评估群体免疫水平。:我们的结果表明,每种病毒的免疫水平各不相同,特定人群显示出不同的免疫水平。本研究期间麻疹总血清阳性率为74.7%,各年龄组差异显著。虽然儿童(90.7%)和老年组(98.4%)的血清阳性率较高,但30至49岁的中年个体的IgG水平显著较低。2021年至2023年期间,塞尔维亚未检测到风疹登记病例,这表明免疫水平较高。所有年龄组的IgG水平持续较高,平均血清阳性率为94.8%,证实了这一点。所有年龄组的腮腺炎平均血清阳性率为85.1%。最低值出现在幼儿(1至5岁)年龄组(76.1%);最高值出现在老年组(92.6%)。:目前的研究结果表明,贝尔格莱德人群对MMR具有较强的总体免疫力,但中年成年人的麻疹免疫力存在一些问题,这表明可能需要进行补种疫苗。虽然风疹状况表明群体免疫力强且爆发风险最小,但某些群体(儿童、中年成年人)的腮腺炎免疫力低于保护阈值。虽然这仍然足以防止广泛传播,但应密切观察。据我们所知,这项研究是同类研究中第一项提供贝尔格莱德MMR血清阳性率数据的研究。研究结果表明需要对弱势群体/血清阴性群体进行持续监测和重新接种疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/0f3d50351767/vaccines-13-00652-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验